ArticleOPEN ACCESS

KRAS Mutation as a Resistance Mechanism to BRAF/MEK Inhibition in NSCLC

Journal of Thoracic Oncology
DOI: 10.1016/j.jtho.2018.07.103
36Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Niemantsverdriet, M., Schuuring, E., Elst, A. ter, van der Wekken, A. J., van Kempen, L. C., van den Berg, A., & Groen, H. J. M. (2018, December 1). KRAS Mutation as a Resistance Mechanism to BRAF/MEK Inhibition in NSCLC. Journal of Thoracic Oncology. Elsevier Inc. https://doi.org/10.1016/j.jtho.2018.07.103

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free